Lataa...
Punicalagin protects H9c2 cardiomyocytes from doxorubicin-induced toxicity through activation of Nrf2/HO-1 signaling
Doxorubicin (DOX) is a wide-spectrum antitumor agent, but its clinical application is largely limited by its cardiotoxicity. Therefore, identification of effective agents against DOX-induced cardiotoxicity is of critical importance. The present study aimed to determine the beneficial role of punical...
Tallennettuna:
| Julkaisussa: | Biosci Rep |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Portland Press Ltd.
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6522706/ https://ncbi.nlm.nih.gov/pubmed/31015369 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1042/BSR20190229 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|